Please use this identifier to cite or link to this item:
|Title:||Ethical considerations in choosing a model for population-based cystic fibrosis carrier screening.||Austin Authors:||Modra, Lucy J ;Massie, R John;Delatycki, Martin B||Affiliation:||Austin Health, Heidelberg, Victoria, Australia, Australia||Issue Date:||2-Aug-2010||Publication information:||Medical Journal of Australia; 193(3): 157-60||Abstract:||Cystic fibrosis (CF) carrier testing can be used to inform reproductive decision making, allowing carriers to avoid having a child with CF. A government-funded, population-based CF carrier screening program would allow greater equity of access to this test. The setting in which CF carrier screening is offered significantly affects the extent to which participants make well informed, voluntary decisions to accept or decline testing. Screening offered before pregnancy and in non-clinical environments better promotes participant autonomy than screening offered in the prenatal consultation.||Gov't Doc #:||20678044||URI:||http://ahro.austin.org.au/austinjspui/handle/1/11094||URL:||https://pubmed.ncbi.nlm.nih.gov/20678044||Type:||Journal Article||Subjects:||Choice Behavior
Cystic Fibrosis.genetics.prevention & control
|Appears in Collections:||Journal articles|
Show full item record
checked on Dec 2, 2022
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.